In vitro activity of amoxycillin/clavulanate and ticarcillin/clavulanate compared with that of other antibiotics against anaerobic bacteria: Comparison with the results of the 1987 survey

Acta Clinica Belgica

Volumn 51, Issue 2, 1996, Pages 70-79

  Pierard, D ^a,i   De Meyer, A ^a   Rosseel, P ^a   Van Cauwenbergh, M ^a   Struelens, M J ^b   Delmee, M ^c   Goossens, H ^d   Claeys, G ^e   Glupczynski, Y ^f   Verbist, L ^g   Melin, P ^h   Lauwers, S ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^d ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^e GHENT UNIVERSITY HOSPITAL   (Belgium)

^f CHU Andre Vesale   (Belgium)

^g UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^h UNIVERSITY OF LIÈGE   (Belgium)

ⁱ UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAMASE; CEFOXITIN; CHLORAMPHENICOL; CLAVULANIC ACID; CLINDAMYCIN; IMIPENEM; METRONIDAZOLE; PENICILLIN G; PIPERACILLIN; TAZOBACTAM; TICARCILLIN; TIMENTIN;

ANAEROBIC BACTERIUM; ARTICLE; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; BACTEROIDES FRAGILIS; BELGIUM; CLOSTRIDIUM; CONTROLLED STUDY; NONHUMAN;

AMOXICILLIN; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; BACTERIA, ANAEROBIC; CLAVULANIC ACIDS; DRUG THERAPY, COMBINATION; MICROBIAL SENSITIVITY TESTS; TICARCILLIN;

EID: 0029882344     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1080/17843286.1996.11718489     Document Type: Article

References (12)

1. National Committee for Laboratory Standards. Reference Agar Dilution Procedure for Antimicrobial Susceptibility of Anaerobic Bacteria M11-A3, NCCLS, Villanova, PA 1993.
2. Pierard D, De Meyer A, Rosseel P et al. In vitro activity of amoxycillin plus clavulanic acid and ticarcillin plus clavulanic acid compared with that of other antibiotics against anaerobic bacteria. Acta Clin Belg. 1989; 44: 228-35.
3. Dubreuil L. Bêtalactamases des anaérobies stricts: intérêt médical. La Lettre de l'Infectiologue. 1995; 10: 64-76.
4. Finegold SM. Anaerobic infections in humans: an overview. Anaerobe. 1995; 1: 3-9.
5. Summanen P, Baron EJ, Citron DM, Strong C, Wexler HM, Finegold SM. Wadsworth Anaerobic Bacteriology Manual. Belmont, CA: Star Publishing Company, 1993.
6. National Committee for Laboratory Standards. Performance standards for antimicrobial susceptibility testing, sixth informational supplement M100-S6, NCCLS, Villanova, PA 1995.
7. Glupczynski Y, Yourassowsky E. Multicenter in vitro study of the susceptibility of the Bacteroides fragilis group in Belgium. Acta Clin Belg. 1986; 41: 167-72.
8. Edwards R, Greenwood D. An investigation of betalactamases from clinical isolates of Bacteroides species. J Med Microbiol. 1992; 36: 89-95.
9. Jacobs MR, Splangler SK, Appelbaum PC. Betalactamase production and susceptibility of US and European anaerobic Gram-negative bacilli to betalactams and other agents. Eur J Clin Microbiol Infect Dis. 1992; 11: 1081-93.
10. Martin C, Dubreuil L, Sedallian A, Romond C. Détection des betalactamases des Bacteroides du groupe fragilis. Pathol Biol. 1990; 38: 470-3.
11. Patey O, Varon E, Prazuck T et al. Multicentre survey in France of the antimicrobial susceptibilities of 416 blood culture isolates of the Bacteroides fragilis group. J Antimicrob Chemother. 1994: 33: 1029-34.
12. Breuil J, Dublanchet A, Truffaut N, Sebald M. Transferable 5-nitroimidazole resistance in the Bacteroides fragilis group. Plasmid. 1989; 21: 151-4.